Cervenka, Simon http://orcid.org/0000-0001-8103-6977
Frick, Andreas http://orcid.org/0000-0003-2516-9075
Bodén, Robert http://orcid.org/0000-0002-2198-8842
Lubberink, Mark
Funding for this research was provided by:
Vetenskapsrådet (523–2014–3467, 2016-02362)
Article History
Received: 22 December 2021
Revised: 20 May 2022
Accepted: 25 May 2022
First Online: 14 June 2022
Competing interests
: ML is co-founder and part-time employee of Medtrace Pharma A/S. All other authors report no conflicts of interest.